Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Top Articles of 2024, #10: Novo Nordisk’s Fight Against Ozempic Counterfeits

The #10 most clicked article of 2024: Investigations by the pharmaceutical giant into the proliferation of fake versions of its medicine highlight how drugmakers can be proactive, collaborate with authorities on tackling counterfeiting.

Injectables like Novo Nordisk's Ozempic run the risk of counterfeit relabeling.
Injectables like Novo Nordisk's Ozempic run the risk of counterfeit relabeling.

The diabetes drug Ozempic has been a hit for manufacturer Novo Nordisk. But its meteoric rise in popularity brings with it concerns for the patent holder due to emerging reports of patient harm and the widespread availability of counterfeit versions worldwide.

That’s why the Denmark-based drugmaker is taking a proactive approach, testing suspect products and collaborating with authorities to try to uncover the origin of the fake versions. A recent Reuters article discussed how Novo Nordisk's CEO, Lars Fruergaard Jorgensen, is addressing the situation through collaborative efforts with the U.S. Food and Drug Administration (FDA) and other authorities in numerous countries. "We cannot take action on our own,” he explained to Reuters.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?